LCTX
Price
$1.67
Change
-$0.03 (-1.76%)
Updated
Jan 15, 11:46 AM (EDT)
Capitalization
391.56M
49 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$4.75
Change
-$0.10 (-2.06%)
Updated
Jan 15, 12:07 PM (EDT)
Capitalization
2.52B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LCTX vs RXRX

Header iconLCTX vs RXRX Comparison
Open Charts LCTX vs RXRXBanner chart's image
Lineage Cell Therapeutics
Price$1.67
Change-$0.03 (-1.76%)
Volume$300
Capitalization391.56M
Recursion Pharmaceuticals
Price$4.75
Change-$0.10 (-2.06%)
Volume$44.45K
Capitalization2.52B
LCTX vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
LCTX vs. RXRX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (LCTX: $1.70 vs. RXRX: $4.85)
Brand notoriety: LCTX and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 49% vs. RXRX: 73%
Market capitalization -- LCTX: $391.56M vs. RXRX: $2.52B
LCTX [@Biotechnology] is valued at $391.56M. RXRX’s [@Biotechnology] market capitalization is $2.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LCTX is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • LCTX’s TA Score: 4 bullish, 4 bearish.
  • RXRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than LCTX.

Price Growth

LCTX (@Biotechnology) experienced а -7.10% price change this week, while RXRX (@Biotechnology) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

LCTX is expected to report earnings on Mar 05, 2026.

RXRX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.52B) has a higher market cap than LCTX($392M). RXRX YTD gains are higher at: 18.582 vs. LCTX (1.796). LCTX has higher annual earnings (EBITDA): -19.68M vs. RXRX (-636.09M). RXRX has more cash in the bank: 660M vs. LCTX (40.5M). LCTX has less debt than RXRX: LCTX (2.62M) vs RXRX (82.4M). RXRX has higher revenues than LCTX: RXRX (43.4M) vs LCTX (10.8M).
LCTXRXRXLCTX / RXRX
Capitalization392M2.52B16%
EBITDA-19.68M-636.09M3%
Gain YTD1.79618.58210%
P/E RatioN/AN/A-
Revenue10.8M43.4M25%
Total Cash40.5M660M6%
Total Debt2.62M82.4M3%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LCTXRXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TLVAX22.810.19
+0.84%
Timothy Plan Large/Mid Cap Value A
AEDAX34.320.18
+0.53%
Invesco International Value A
MRSAX26.820.03
+0.11%
MFS Research International A
TGRIX14.11-0.04
-0.28%
American Century International Gr I
TBLRX10.17-0.03
-0.29%
Transamerica Balanced II R

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+1.80%
MDGL - LCTX
43%
Loosely correlated
+2.29%
ABCL - LCTX
39%
Loosely correlated
+0.47%
CRSP - LCTX
37%
Loosely correlated
+1.26%
RXRX - LCTX
36%
Loosely correlated
+3.41%
VIR - LCTX
36%
Loosely correlated
+8.08%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+3.41%
CRSP - RXRX
68%
Closely correlated
+1.26%
ABSI - RXRX
66%
Closely correlated
+1.21%
BEAM - RXRX
62%
Loosely correlated
+2.49%
ABCL - RXRX
58%
Loosely correlated
+0.47%
PRME - RXRX
54%
Loosely correlated
+3.61%
More